Read the full transcript here.

Why has there been such an explosion of progress in genomics recently? What's the right way to think about how genes affect the likelihood of experiencing certain health outcomes? How can people mitigate genetic risks for their potential children? What sorts of moral obligations (if any) do parents have to mitigate potential genetic risks for their children? How does Orchid's focus differ from other companies in the same space? What is "junk" DNA? What percentage of our genes are identical to our siblings, to other humans, and even to other animals?

Noor Siddiqui is the Founder and CEO of Orchid, a reproductive technology company. Prior to Orchid, Noor was an AI researcher at Stanford where she worked on applications of deep learning to genomics with Anshul Kundaje and computer vision applied to medical imaging with Sebastian Thrun. Noor has spoken internationally about her work at the intersection of technology and medicine at events like Milken's Global Conference, WebSummit, and Kaiser Permanente's Executive Leadership Summit. Her work has been covered by The Washington Post, Forbes, TechCrunch, among other outlets. Noor is also a recipient of the Thiel Fellowship, a grant program spawned by Paypal founder and Facebook board member, Peter Thiel, supporting breakthrough technology companies. Noor earned her M.S. and B.S. in Computer Science from Stanford University. Follow her on Twitter, connect with her on LinkedIn, visit her website, or email her at noorsiddiqui@orchidhealth.com.

Staff

Spencer Greenberg — Host / Director
Josh Castle — Producer
Ryan Kessler — Audio Engineer
Uri Bram — Factotum
Janaisa Baril — Transcriptionist

Music

Affiliates

[Read more]

Genomics and Health Outcomes (with Noor Siddiqui)

Clearer Thinking with Spencer Greenberg